Replies to post #15113 on RespireRx Pharmaceuticals Inc (RSPI)

[enemem]

For sure, $2-$3 beats $0.50, but in the context of the potential upside for this stock, $2-$3 is very much at the low end of that. This disappointment will sharpen if the company that buys out COR makes tons of money on the purchased IP.